Danning Dong
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Tao Dong (3 shared papers)Peiwen Fan (5 shared papers)Xuan Yao (4 shared papers)Yanchun Peng (4 shared papers)Catherine J. Luke (1 shared paper)Beibei Wang (1 shared paper)Ruozheng Wang (4 shared papers)Hui Zeng (1 shared paper)
- Journals
- Nature Immunology (2 papers)Frontiers in Oncology (2 papers)Frontiers in Immunology (1 paper)iScience (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomChinaUnited States
In The Last Decade
Danning Dong
9 papers receiving 1.2k citations
Danning Dong's Hit Papers
Peers
Comparison fields: 5 of 44
- Infectious Diseases 1k
- Immunology 88
- Molecular Biology 190
- General Dentistry 1
- Oncology 40
Countries citing papers authored by Danning Dong
This map shows the geographic impact of Danning Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danning Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danning Dong more than expected).
Fields of papers citing papers by Danning Dong
This network shows the impact of papers produced by Danning Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danning Dong. The network helps show where Danning Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Danning Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Hit paper breakdown → | 2020 | 998 |
| 2 | 2021 | 137 | |
| 3 | 2021 | 68 | |
| 4 | 2015 | 22 | |
| 5 | 2021 | 15 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2025 | 0 | |
| 11 | 2025 | 0 |
About Danning Dong
Danning Dong is a scholar working on Infectious Diseases, Oncology, Otorhinolaryngology, Epidemiology and Immunology, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), vaccines and immunoinformatics approaches (2 papers), Influenza Virus Research Studies (1 paper), Immune Cell Function and Interaction (1 paper), Cervical Cancer and HPV Research (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Infectious Diseases (1k citations), Immunology (88 citations), Molecular Biology (190 citations), General Dentistry (1 citation) and Oncology (40 citations). Danning Dong has collaborated with scholars based in United Kingdom, China and United States. Frequent co-authors include Tao Dong, Peiwen Fan, Xuan Yao, Yanchun Peng, Catherine J. Luke, Beibei Wang, Ruozheng Wang, Hui Zeng, Ruth A. Karron and Kawsar R. Talaat. Their work appears in journals such as Nature Immunology, Frontiers in Oncology, Frontiers in Immunology, iScience and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.